• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Youngevity International, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    7/11/22 5:15:23 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services
    Get the next $YGYI alert in real time by email
    yii20220710_8k.htm
    false 0001569329 0001569329 2022-07-06 2022-07-06
     


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (date of earliest event reported): July 6, 2022
     
    YOUNGEVITY INTERNATIONAL, INC.
    (Exact name of registrant as specified in its charter)
     
    Delaware
    001-38116
    90-0890517
    (State or other jurisdiction of incorporation)
    (Commission File No.)
    (IRS Employer Identification No.)
     
    2400 Boswell Road, Chula Vista, CA 91914
    (Address of principal executive offices) (Zip Code)
     
     
    Registrant’s telephone number, including area code: (619) 934-3980
     
    N/A
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
     


     
     

     
     
    Item 1.01. Entry into a Material Definitive Agreement.
     
    On July 6, 2022, CLR Roasters, LLC (“CLR”), a wholly owned subsidiary of Youngevity International, Inc. (the “Company”), entered into a loan and security agreement (the “Loan and Security Agreement”) with GemCap Solutions, LLC (“GemCap”) pursuant to which CLR issued to GemCap a secured revolving loan promissory note in the principal sum of up to $4,000,000 (the “Note”). The Loan and Security Agreement provides for a line of credit in an amount equal to the lesser of (a) $4,000,000 or (b) the Borrowing Base, which is defined as the sum of (A) the product obtained by multiplying the outstanding amount of all eligible accounts receivable, net of all taxes, discounts, allowances and credits given or claimed, by up to 80%, plus (B) the lesser of (i) the product obtained by multiplying the cost of then-existing eligible inventory by 70% and (i) the sum of (x) which is the product obtained by multiplying the lower of cost or market price of then-existing eligible green coffee inventory by 60% and (y) the product obtained by multiplying the lower of cost or market price of then-existing eligible roasted inventory by 70%.
     
    The outstanding principal balance of the line of credit bears interest based upon a 360-day year with interest charged for each day the principal amount is outstanding including the date of actual payment. The interest rate is a rate equal to the greater of (a) 7.50% or (b) the sum of the prime rate plus 3.50%. At closing, the GemCap line of credit was used to pay off CLR’s line of credit balance with Crestmark Bank of approximately $1,717,000.
     
    As collateral security for the payment and performance of the obligations, CLR granted and conveyed to GemCap a first priority continuing security interest in and lien upon all owned and hereafter acquired or created property and assets of CLR and the proceeds and products thereof, which property, assets and proceeds, together with all other collateral security for the obligations granted to or otherwise acquired by GemCap, is considered collateral, such as, accounts receivables, inventory, deposit accounts, property and equipment and intangible assets.
     
    The Loan and Security Agreement contains certain financial and nonfinancial covenants with which the Company must comply to maintain its borrowing availability and avoid penalties, such as a prohibition on additional indebtedness and other liens. The Note matures in June 2024. In addition, pursuant to a Secured Continuing Guarantee, dated July 6, 2022 (the “Guarantee”), the Company’s Chief Executive Officer and Chief Operating Officer personally guaranteed CLR’s obligations to GemCap under the Loan and Security Agreement.
     
    The Loan and Security Agreement contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in the Loan and Security Agreement were made only for purposes of such agreement and as of a specific date, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.
     
    The foregoing descriptions of the terms of the Loan and Security Agreement, the Note and the Guarantee are qualified in their entirety by reference to the full text of the Loan and Security Agreement, the Note and the Guarantee, copies of which are filed as Exhibits 10.1, 10.2 and 10.3, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
     
    Item 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-balance Sheet Arrangement of a Registrant.
     
    The information set forth under Item 1.01 above of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.
     
     
    Item 9.01. Financial Statements and Exhibits.
     
    (d) Exhibits.
     
    The following exhibits are filed with this Current Report on Form 8-K:
     
    Exhibit
    Number
     
    Description
         
    10.1
     
    Loan and Security Agreement, dated July 6, 2022, by and between CLR Roasters, LLC and GemCap Solutions, LLC
    10.2
     
    Secured Promissory Note (Revolving Loans), dated July 6, 2022, by and between GemCap Solutions, LLC and CLR Roasters LLC
    10.3
     
    Secured Continuing Guarantee, dated July 1, 2022, executed by Stephan Wallach and Michelle Wallach, by and between GemCap Solutions, LLC and CLR Roasters LLC
    104
     
    Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)
     
    -2-

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
     
    YOUNGEVITY INTERNATIONAL, INC.
     
           
    Date: July 11, 2022
    By:
    /s/ David Briskie
     
      Name:
    David Briskie
     
      Title:
    President and Chief Investment Officer
     
     
     
    -3-
    Get the next $YGYI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $YGYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $YGYI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Youngevity International, Inc Granted Motion for Summary Judgement Against Former President Dwayne Dundore

    Florida Court Issues Order Awarding Youngevity Damages of $20,915,507 SAN DIEGO, Sept. 21, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTCMRKTS: YGYI) ("Youngevity") and its subsidiary Khrysos Industries, Inc today announced that the Circuit Court of the Ninth Judicial Circuit in and for Orange County, Florida, has issued an order against former Khrysos President Dwayne Dundore granting Youngevity's Motion for Summary Judgement on Counts III (Fraudulent Inducement) and IV (Breach Of Employment Agreement), awarding Youngevity $20,915,507 in damages.  A complete copy of

    9/21/22 8:30:00 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. Provides Update on Financial Reporting and Files Forms 10-Q for Quarters Ended March 31, June 30, and September 30, 2020

    SAN DIEGO, June 22, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTC:YGYI), ("YGYI" or the "Company"), a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise, a direct marketing enterprise, and a nutraceutical manufacturing enterprise, today reported financial results for the quarters ended March 31, June 30, and September 30, 2020. Steve Wallach, Chairman and CEO of Youngevity International stated, "We are making progress toward reaching fully reporting status with the filing of our 10-Qs for the first

    6/22/22 9:22:00 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. Announces Declaration of Monthly Dividend for May 2022 for Series "D" Cumulative Redeemable Perpetual Preferred Stock

    SAN DIEGO, May 20, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTC:YGYI), ("YGYI" or the "Company"), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTC:YGYIP) for May 2022.  The dividend will be payable on June 15, 2022, to holders of record as of May 31, 2022. The dividend will be paid in cash. About Youngevity International, Inc. Youngevity International, Inc. is a multi-channel lifestyle company operating in three distinct business segments including a com

    5/20/22 8:30:00 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    $YGYI
    SEC Filings

    View All

    SEC Form REVOKED filed by Youngevity International, Inc.

    REVOKED - Youngevity International, Inc. (0001569329) (Filer)

    12/6/23 10:32:42 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Youngevity International, Inc. (0001569329) (Filer)

    7/11/22 5:15:23 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    SEC Form 10-Q filed by Youngevity International, Inc.

    10-Q - Youngevity International, Inc. (0001569329) (Filer)

    6/22/22 8:52:54 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    $YGYI
    Financials

    Live finance-specific insights

    View All

    Youngevity International, Inc. Announces Declaration of Monthly Dividend for May 2022 for Series "D" Cumulative Redeemable Perpetual Preferred Stock

    SAN DIEGO, May 20, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTC:YGYI), ("YGYI" or the "Company"), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTC:YGYIP) for May 2022.  The dividend will be payable on June 15, 2022, to holders of record as of May 31, 2022. The dividend will be paid in cash. About Youngevity International, Inc. Youngevity International, Inc. is a multi-channel lifestyle company operating in three distinct business segments including a com

    5/20/22 8:30:00 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. Announces Declaration of Monthly Dividend for April 2022 for Series "D" Cumulative Redeemable Perpetual Preferred Stock

    SAN DIEGO, April 19, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTCM: YGYI), ("YGYI" or the "Company"), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTC:YGYIP) for April 2022.  The dividend will be payable on May 16, 2022, to holders of record as of April 29, 2022. The dividend will be paid in cash. About Youngevity International, Inc. Youngevity International, Inc. is a multi-channel lifestyle company operating in three distinct business segments includin

    4/19/22 5:04:00 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. Announces Declaration of Monthly Dividend for the 1st Quarter 2022 for Series "D" Cumulative Redeemable Perpetual Preferred Stock

    SAN DIEGO, Jan. 14, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTC:YGYI), ("YGYI" or the "Company"), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTC:YGYIP) for each of January, February and March 2022.  The dividend will be payable on February 15, 2022, March 15, 2022, and April 15, 2022, to holders of record as of January 31, 2022, February 28, 2022, and March 31, 2022. The dividend will be paid in cash. About Youngevity International, Inc. Youngevity In

    1/14/22 12:57:00 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    $YGYI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Youngevity International, Inc.

    SC 13G - Youngevity International, Inc. (0001569329) (Subject)

    5/6/22 3:48:41 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    SEC Form SC 13G filed

    SC 13G - Youngevity International, Inc. (0001569329) (Subject)

    3/11/21 2:31:16 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services